124 related articles for article (PubMed ID: 8153785)
21. Human immunodeficiency virus infection and hypereosinophilic syndrome. An increasingly recognized association.
Morgan MB; Viloria J; Morgan JD; Suarez-Hoyos J
J Fla Med Assoc; 1994 Jun; 81(6):401-2. PubMed ID: 8064280
[No Abstract] [Full Text] [Related]
22. Isolated symptomatic cutaneous disease in hypereosinophilic syndrome.
Preda V; Henderson C; Woods J
Australas J Dermatol; 2010 Feb; 51(1):60-5. PubMed ID: 20148847
[TBL] [Abstract][Full Text] [Related]
23. Idiopathic hypereosinophilic syndrome: a new cause of vasculitis of the central nervous system.
Rice CM; Kurian KM; Renowden S; Whiteway A; Price C; Scolding NJ
J Neurol; 2015 May; 262(5):1354-9. PubMed ID: 25843450
[TBL] [Abstract][Full Text] [Related]
24. Hypereosinophilic syndrome with cutaneous manifestations successfully treated with Dupilumab as a sole agent: A case report.
Scully K; Shao E; Banney L; Weston H
Australas J Dermatol; 2023 Aug; 64(3):400-403. PubMed ID: 37247253
[TBL] [Abstract][Full Text] [Related]
25. Management of Hypereosinophilic Syndromes.
Roufosse F
Immunol Allergy Clin North Am; 2015 Aug; 35(3):561-75. PubMed ID: 26209900
[TBL] [Abstract][Full Text] [Related]
26. Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5.
Trüeb RM; Lübbe J; Torricelli R; Panizzon RG; Wüthrich B; Burg G
Arch Dermatol; 1997 Feb; 133(2):203-6. PubMed ID: 9041834
[TBL] [Abstract][Full Text] [Related]
27. Cardiac involvement in hypereosinophilic syndrome.
ten Oever J; Theunissen LJ; Tick LW; Verbunt RJ
Neth J Med; 2011 May; 69(5):240-4. PubMed ID: 21793262
[TBL] [Abstract][Full Text] [Related]
28. Idiopathic hypereosinophilic syndrome with cutaneous involvement: a comparative review of 32 cases.
Inayat F; O'Neill SS; Zafar F; Marupudi S; Vasim I
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567176
[TBL] [Abstract][Full Text] [Related]
29. Treatment of hypereosinophilic syndrome and eosinophilic dermatitis with reslizumab.
Kuruvilla M
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):670-671. PubMed ID: 29496465
[No Abstract] [Full Text] [Related]
30. Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome.
Kay AB; Klion AD
Immunol Allergy Clin North Am; 2004 Nov; 24(4):645-66, vii. PubMed ID: 15474864
[TBL] [Abstract][Full Text] [Related]
31. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy--case report and literature review.
Baratta L; Afeltra A; Delfino M; De Castro S; Giorgino F; Rossi-Fanelli F
Angiology; 2002; 53(4):465-70. PubMed ID: 12143954
[TBL] [Abstract][Full Text] [Related]
32. Treatment of hypereosinophilic syndrome with imatinib mesilate.
Gleich GJ; Leiferman KM; Pardanani A; Tefferi A; Butterfield JH
Lancet; 2002 May; 359(9317):1577-8. PubMed ID: 12047970
[TBL] [Abstract][Full Text] [Related]
33. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes.
Bank I; Amariglio N; Reshef A; Hardan I; Confino Y; Trau H; Shtrasburg S; Langevitz P; Monselise Y; Shalit M; Rechavi G
Leuk Lymphoma; 2001 Jun; 42(1-2):123-33. PubMed ID: 11699199
[TBL] [Abstract][Full Text] [Related]
34. Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients.
Helbig G; Wiśniewska-Piąty K; Francuz T; Dziaczkowska-Suszek J; Kyrcz-Krzemień S
Leuk Lymphoma; 2013 Apr; 54(4):807-11. PubMed ID: 22988896
[TBL] [Abstract][Full Text] [Related]
35. [A case of idiopathic hypereosinophilic syndrome with hepatic involvement in a 5-year-old boy].
Kim YM; Lee YJ; Park JH; Lee JW; Lee CH
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):321-6. PubMed ID: 12499791
[TBL] [Abstract][Full Text] [Related]
36. Acute Liver Failure Due to Hypereosinophilic Syndrome Accompanied by Duodenal Perforation.
Tange S; Uchino K; Kakiwaki H; Suzuki H; Yamamoto S; Ito Y; Taniguchi H; Shirai H; Suzuki T; Onoyama H; Nagaoka S; Kumasaka T; Yoshida H
Intern Med; 2022 May; 61(10):1525-1529. PubMed ID: 34670898
[TBL] [Abstract][Full Text] [Related]
37. The idiopathic hypereosinophilic syndrome.
Lin DA; Boyce JA
Allergy Asthma Proc; 2003; 24(6):417-20. PubMed ID: 14763243
[TBL] [Abstract][Full Text] [Related]
38. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
Garrett JK; Jameson SC; Thomson B; Collins MH; Wagoner LE; Freese DK; Beck LA; Boyce JA; Filipovich AH; Villanueva JM; Sutton SA; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2004 Jan; 113(1):115-9. PubMed ID: 14699394
[TBL] [Abstract][Full Text] [Related]
39. Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.
Nadarajah S; Krafchik B; Roifman C; Horgan-Bell C
Pediatrics; 1997 Apr; 99(4):630-3. PubMed ID: 9093318
[No Abstract] [Full Text] [Related]
40. [Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome].
Billon C; Gautier C; Villaret E; Ducos MH; Martin JC; Geniaux M
Ann Dermatol Venereol; 1997; 124(3):248-50. PubMed ID: 9686058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
